| Literature DB >> 23617202 |
Claude Samba1, Félicité Tchibindat, Bernard Gourmel, Patrick Houzé, Denis Malvy.
Abstract
Vitamin A status in a sample of pregnant and lactating women living in several representative regions of Congo was assessed and compared between August and September 2004. This survey was conducted using a randomized two-stage cluster-sampling method with stratification on 90 clusters, each consisting of at least 15 women. Vitamin A status was determined in a total of 1,054 individuals, using the impression cytology with transfer (ICT) test, the modified relative dose response test (MRDR test) on dried blood spots (DBS), and clinical examination to detect signs of xerophthalmia. The clinical criterion defining vitamin A deficiency was the presence of active xerophthalmia (Bitot's spots [X1B]), active corneal disease), and/or night blindness (XN stage). The prevalence of clinical signs of stage XN and X1B xerophthalmia in the Republic of Congo was found to be 16% and 19% respectively. The prevalence of clinical signs (X1B) was greater in the rural north than in urban areas, with a gradient running from urban (5%) to rural area (33%); 27% of all the ICT tests showed that the subjects were suffering from vitamin A deficiency. The deficiency rates were significantly higher (p < 0.001) in urban surroundings (Brazzaville) than in the rural northern regions. The biochemical MRDR test showed the presence of vitamin A deficiency (> or = 0.06) in 26% of the mothers in Brazzaville compared to 6% in the town of Kouilou; 44% of the women had retinol levels of < 10 microg/dL in the rural north whereas these percentages were significantly lower in the urban areas surveyed (chi-square = 62.30, p < 0.001). A significant correlation was found to exist (p < 0.001) between the ICT test and the MRDR test on DBS. In the population as a whole, 30% of the mothers suffering from malarial attack had abnormally low MRDR levels (> or = 0.06) compared to no malaria. The results of the present study confirm that vitamin A deficiency is a serious public-health issue in pregnant and lactating mothers in the Republic of Congo.Entities:
Mesh:
Year: 2013 PMID: 23617202 PMCID: PMC3702356 DOI: 10.3329/jhpn.v31i1.14746
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
FigureFlow-chart of enrolled pregnant and lactating women in the Republic of Congo
Characteristics of the populations studied, based on the 2004 Congolese nutritional survey
| Condition of women | N (%), 95% CI | |||
|---|---|---|---|---|
| Brazzaville (urban) | Kouilou (urban) | Rural north (northern forest) | All samples | |
| Pregnant | 110/348 (32.0), 27.0-37.0 | 62/341 (18.0), 13.8-22.2 | 147/365 (40.0), 34.9-45.1 | 319/1,054 (30.0), 27.2-32.8 |
| Lactating | 238/348 (68.0), 63.0-73.0 | 279/341 (82.0), 77.8-86.2 | 218/365 (60.0), 54.9-65.1 | 735/1,054 (70.0), 67.2-72.8 |
| No occupational activity | 268/348 (77.0), 72.5-81.5 | 248/341 (73.0), 68.2-78.0 | 286/365 (78.0), 74.0-82.3 | 802/1,054 (76.0), 73.4-79.0 |
| Follow-up during pregnancy | 310/348 (89.0), 85.7-92.3 | 289/341 (85.0), 81.1-88.9 | 295/365 (81.0), 76.9-85.1 | 894/1,054 (85.0), 82.8-87.2 |
| Vitamin A capsules | 112/348 (32.0), 27.0-37.0 | 74/341 (22.0), 17.5-26.5 | 120/365 (33.0), 28.1-37.9 | 306/1,054 (29.0), 26.2-31.8 |
| Ocular infection | 160/348 (46.0), 40.7-51.3 | 180/341 (53.0), 47.6-58.4 | 12/365 (3.0), 1.2-4.8 | 352/1,054 (33.0), 30.1-35.9 |
| Night blindness (XN) | 45/348 (13.0), 9.4-16.6 | 41/341 (12.0), 8.5-15.5 | 81/365 (22.0), 17.7-26.3 | 167/1,054 (16.0), 13.7-18.3 |
| Xerophthalmia Bitot spots (X1B) | 68/348 (19.0), 14.8-23.2 | 18/341 (5.0), 2.6-7.4 | 119/365 (33.0), 28.1-37.9 | 205/1,054 (19.0), 16.6-21.4 |
| Malarial attacks | 57/348 (16.0), 12.1-19.9 | 17/341 (5.0), 2.6-7.4 | 53/365 (15.0), 11.3-18.7 | 127/1,054 (12.0), 10.0-14.0 |
| Fever-related symptoms | 44/348 (13.0), 9.4-16.6 | 16/341 (5.0), 2.6-7.4 | 64/365 (18.0), 14.0-22.0 | 124/1,054 (12.0), 10.0-14.0 |
N (%)=Number (percentage) of the women, 95% CI=Confidence interval
Classification of the four cytological stages based on ICT tests
| Presence or absence of goblet ells | Appearance of the epithelial cells | Stages | Results |
|---|---|---|---|
| Present | Numerous, small, in clusters | N | Negative |
| Present | Numerous, more small than enlarged cells occurring separately | M+ | Negative |
| Absent: mucin spots present | More enlarged, separate cells than small cells occurring in clusters | M- | Positive |
| Absent | Enlarged, separate | D | Positive |
N=Normal; M+=Marginal plus;
M-=Marginal minus; D=Vitamin A-deficient;
*Based on impression cytology with transfer test
ICT and MRDR test results in pregnant and lactating Congolese women
| Test | N (%), 95% CI | |||
|---|---|---|---|---|
| All samples | ||||
| Normal | 222/348 (64.0), 59.0-69.0 | 253/341 (74.0), 69.3-78.5 | 255/365 (70.0), 45.0-49.0 | 730/1,054 (69.0), 66.0-72.0 |
| Marginal+ | 7/348 (2.0), 0.5-3.5 | 1/341 (0.3), 0.0-0.9 | 10/365 (3.0), 4.0-6.0 | 18/1,054 (2.0), 0.9-2.5 |
| Marginal- | 2/348 (1.0), 0.6-1.4 | 9/341 (2.7), 2.2-3.2 | 14/365 (4.0), 6.0-8.0 | 25/1054 (2.4), 1.5-3.4 |
| Deficient | 117/348 (33.0), 29.0-39.0 | 78/341 (23.0), 18.5-27.5 | 86/365 (23.6), 19.1-28.1 | 281/1,054 (27.0), 24.3-29.7.0 |
| All samples | 348 | 341 | 365 | 1,054 |
| ≥0.06 | 10/39 (26.0), 12.0-40.0 | 3/55 (6.0), 5.0-6.0 | nd | 13/94 (14.0), 5.3-18.7 |
| <0.06 | 29/39 (74.0), 60.0-88.0 | 52/55 (94.0), 93.0-94.0 | nd | 81/94 (86.0), 81.3-94.7 |
| N (%), Mean±SD | ||||
| <10 | 5/39 (13.0), 7.1±1.9 | 14/55 (25.0), 8.9±1.9 | 19/43 (44.0), 6.45±2.35 | 38/137 (28.0), 7.5±2.05 |
| 10-20 | 11/39 (28.0), 13.1±2.1 | 24/55 (44.0), 16.07±2.1 | 10/43 (23.0), 14.55±2.65 | 45/137 (33.0), 14.5±2.3 |
| >20 | 23/39 (59.0), 28.0±6.0 | 17/55 (31.0), 25.3±6.3 | 14/43 (37.0), 31.0±5.4 | 54/137 (39.0), 28.1±5.9 |
Chi-square=49, Degrees of freedom: ddl=6;
*p<0.001; Chi-square=62.30,
**p<0.001; CI=Confidence interval; ICT=Impression cytology with transfer test; nd=Not done; N (%)=Number (percentage) of the women
MRDR levels in pregnant Congolese women in the four ICT stages
| Parameter | Urban Brazzaville | Urban Kouilou | Rural north | All samples | ||||
|---|---|---|---|---|---|---|---|---|
| ICT | (N+ M+) | (M- + D) | (N+ M+) | (M- + D) | (N+ M+) | (M+ D) | (N+ M+) | (M- + D) |
| MRDR ≥0.06 | 14 | 20 | 14 | 23 | nd | nd | 37 | 34 |
| MRDR <0.06 | 3 | 2 | 4 | 2 | nd | nd | 7 | 4 |
| All samples | 17 | 22 | 27 | 16 | nd | nd | 44 | 38 |
| N° (%), 95% CI | 14/17 | 20/22 | 23/27 | 14/16 | 37/44 | 34/38 | ||
| (82.0) | (91.0) | (85.0) | (87.5) | nd | nd | (84.0) | (89.0) | |
| 61.0-100 | 78.0-100 | 71.3-9.0 | 71.0-100 | 73.0-95.0 | 79.0-99.0 | |||
nd=not done;
*Relationship between ICT stages and MRDR classes
Sensitivity, specificity, and positive predictive values of conjunctival impression cytology with transfer compared to MRDR in pregnant and lactating Congolese women
| Conjunctival impression cytology | Urban Brazzaville | Urban Kouilou | All samples | |||
|---|---|---|---|---|---|---|
| MRDR | MRDR | MRDR | MRDR | MRDR | MRDR | |
| ≥0.06 | <0.06 | ≥0.06 | <0.06 | ≥0.06 | <0.06 | |
| Abnormal (M-,D) | 20 | 2 | 14 | 2 | 34 | 4 |
| Normal (M+,N) | 14 | 3 | 23 | 4 | 37 | 7 |
| Sensitivity | 91% (20/22) | 88% (14/16) | 90% (34/38) | |||
| x100 | x100 | x100 | ||||
| Specificity | 15% (4/27) | 15% (4/27) | 16% (7/44) | |||
| x100 | x100 | x100 | ||||
| Positive predictive value | 59% | 38% | 90% | |||
D=Vitamin A-deficient;
M+=Marginal plus;
M-=Marginal minus; N=Normal
MRDR test on DBS versus malarial morbidity in Congolese women
| Parameter | N (%), 95% CI | |||
|---|---|---|---|---|
| Urban Brazzaville | Urban Kouilou | Rural north | All samples | |
| MRDR Test | ||||
| 86% (25/29) | 5.5% (3/55) | nd | 30% (28/92) | |
| 73.0-99.0 | 0.5-11.5 | 21.1-39.7 | ||
| No malarial attacks | 26% (10/39) | 95% (60/63) | nd | 14% (13/94) |
| 12.0-40.0 | 89.0-100 | 5.3-18.7 | ||
| Fever-related current symptoms | 62% (18/29) | 5% (3/63) | nd | 23% (21/92) |
| 44.0-80.0 | 0-10.4 | 14.5-31.5 | ||
| <20 µg/dL | <20 µg/dL | <20 µg/dL | <20 µg/dL | |
| 83% (24/29) | 86% (54/63) | 0 | 85% (78/92) | |
| 46.5-100.0 | 62.0-100.0 | 65.0-100.0 | ||
| No Malarial attacks | 41% (16/39) | 69% (38/55) | 67% (29/43) | 61% (83/137) |
| 25.6-56.4 | 56.8-81.2 | 53.0-81.0 | 51.0-68.2 | |
| Fever-related current symptoms | 63% (18/29) | 97% (61/63) | 64% (6/14) | 83% (88/106) |
| 28.0-98.0 | 73.0-100.0 | 43.0-100.0 | 64.0-100.0 | |
*Relationship between MRDR test and malarial attack;
**Relationship between retinol levels and malarial attack; nd=not done